Evidence map›Paper›PMID 40994627›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2025

The Individual Impact of Machine Perfusion on Liver and Kidney on Donor Expansion in Simultaneous Liver and Kidney Transplantation.

Rikako Oki, Ingrid Rocha, Saleh Al-Juburi, Luckshi Rajendran, Emily Kerby, Adhnan Mohamed, Abbas Al-Kurd, Ahmed Nassar, Dean Y Kim, Atsushi Yoshida and 2 more

Abstract read
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Editorial: Current developments in artificial organs and engineeredTransplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  3. Exploring Disease-Specific Waitlist Outcomes in Simultaneous Liver-Kidney Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rikako OkiTransplant Institute, Henry Ford Hospital, Detroit, MI, United States.
Ingrid RochaTransplant Institute, Henry Ford Hospital, Detroit, MI, United States.
Saleh Al-JuburiTransplant Institute, Henry Ford Hospital, Detroit, MI, United States.
Luckshi RajendranDivision of Transplant and Hepatobiliary Surgery, Detroit, MI, United States.
Emily KerbyDivision of Transplant and Hepatobiliary Surgery, Detroit, MI, United States.
Adhnan MohamedDivision of Transplant and Hepatobiliary Surgery, Detroit, MI, United States.
Abbas Al-KurdDivision of Transplant and Hepatobiliary Surgery, Detroit, MI, United States.
Ahmed NassarDivision of Transplant and Hepatobiliary Surgery, Detroit, MI, United States.
Dean Y KimTransplant Institute, Henry Ford Hospital, Detroit, MI, United States.
Atsushi YoshidaDivision of Transplant and Hepatobiliary Surgery, Detroit, MI, United States.
Marwan AbouljoudDivision of Transplant and Hepatobiliary Surgery, Detroit, MI, United States.
Shunji NagaiTransplant Institute, Henry Ford Hospital, Detroit, MI, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Machine perfusion (MP) use for both organs can increase organ usage in simultaneous liver and kidney transplantation (SLKT). We analyzed 6,956 SLKT performed between 2015 and 2024 using the United Network for Organ Sharing database. The primary outcomes were the 1-year graft survival for kidney and liver. Donor types and MP use for liver and/or kidney were captured and associations with outcomes were evaluated. SLKT from Donation after circulatory death donors (DCD) increased from 4.5% in 2015 to 16% in 2023. The median Kidney Donor Profile Index (KDPI) has increased from 23% in 2015 to 28% in 2023. MP use for kidney and liver also increased from 21% to 51% and 0%-17%, respectively. KDPI >85% was an independent risk factor of 1-year kidney graft failure in the no kidney MP group [HR 2.03, 95% CI 1.20-3.44, p = 0.009], but not in the kidney MP group. DCD was found to be an independent risk factor of 1-year liver graft failure in the no liver MP group [HR 1.56, 95% CI 1.19-2.03, p = 0.001], but not in the liver MP group. MP for both organs may contribute to expanding the donor pool for SLKT without compromising post-transplant outcomes.

Indexed as

Kidney TransplantationLiver TransplantationOrgan PreservationPerfusionAdultFemaleGraft SurvivalHumansMaleMiddle AgedRetrospective StudiesRisk FactorsTissue and Organ ProcurementTissue Donorsdonation after circulatory deathdonor expansionkidney donor profile indexmachine perfusionsimultaneous liver and kidney transplantation

Identifiers

PMID40994627
PMCPMC12454159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.